FDA “determined a more streamlined pathway” using information it's received for products available under enforcement discretion “would help provide for the long-term availability and marketing of many” of those products.
Results from the US Food and Drug Administration’s and manufacturers’ responses this year to an infant formula shortage pointed the agency to plan to streamline its procedures for allowing additional firms to market formula.
The agency on 6 July announced it has “determined that a more streamlined pathway” using information it has received for...
HBW Insight speaks to Bayer Consumer Health's global strategy director for regulatory, medical, safety, quality, and compliance Emese Csoke about how least how widening access to self-care solutions can be balanced with equity with regards to affordability.
Health and Human Services secretary made incorrect statements about the status of key industry priorities at a recent House hearing, which actually may be a good thing for drug sponsors.
With annual sales approaching $20m, LupinLife Consumer Healthcare has ambitious growth plans for the Indian OTC market.
